Klea Holding

What Klea Holding does

Klea Holding is a Paris-headquartered international group (formerly Visiomed Group, founded 2007) listed on Euronext Growth Paris under ticker ALKLH. It operates through four healthcare subsidiaries centered on digital health delivery in the Gulf region: Smart Salem (wholly-owned digital medical testing centers in Dubai), Smart Health (a Saudi Arabia joint venture now majority-financed by Mobadara Investment), Klea Pharmaceuticals (a 46%-held subsidiary, with option to 70%, marketing licensed medicines across the Middle East and Africa), and Bewellthy (connected-health and telemedicine).

The core operating asset is the Smart Salem network of three DHA-accredited digital medical centers in Dubai (DIFC, Dubai Knowledge Park, and City Walk). These centers combine AI and virtual-reality-enabled diagnostics with structured medical analytics to screen for approximately 35 diseases — including HIV, hepatitis, and tuberculosis — in around 7 minutes, delivering visa-related medical fitness results in 30 minutes versus the 10–15 days reported at conventional providers. The group also markets VisioCheck, a sub-300g portable telemedicine station for healthcare professionals, and through Bewellthy offers teleconsultation, telemonitoring, and tele-expertise solutions.

Revenue is generated predominantly through per-test transactional fees — averaging AED 430 for visa-related medical fitness tests and AED 1,580 for premium Health & Wellness tests — at the three walk-in Dubai centers, supplemented by B2B corporate wellness engagement. Pharmaceutical distribution in the UAE is executed through a partnership with Al Khayyat Investments, providing access to 1,611 pharmacies and 51 hospital groups. FY2025 group revenue reached €22.2 million, with normalized EBITDA of €6.9 million (31% margin) and net financial debt of approximately €0.1 million, indicating a deleveraged, cash-generative operating model alongside active expansion into Saudi Arabia and pharmaceuticals.

Name

Klea Holding

Legal name

Klea Holding

Website

https://kleaholding.com

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

Klea Holding is a Paris-based international group operating Smart Salem, a network of DHA-accredited digital medical testing centers in Dubai, plus subsidiaries in Saudi Arabia (Smart Health), pharmaceuticals (Klea Pharmaceuticals), and telemedicine (Bewellthy), serving visa applicants and B2B clients.

Ownership category

akta.pro rank

Product category

Digital Medical Diagnostics & Healthcare Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)

akta.pro secondary industry

Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry) (HLAFAKAJ)

Keywords

• Digital medical diagnostics
• Visa medical fitness testing
• Connected health telemedicine
• Pharmaceutical distribution MEA
• Preventive health screening

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Fitness Testing Services: Revenue from medical fitness assessments required for residence and work visas in UAE. Smart Salem network performs health screenings and medical tests for visa purposes. Services are priced per test with volume growth driving revenue. Core business representing approximately 86% of 2025 revenue.
2. Health & Wellness Testing: Preventive health check-ups and wellness testing services for individuals and corporate clients. Higher margin segment growing rapidly (153% growth in 2025 at constant exchange rates). Price increases implemented in H2 2025 reflecting high added value of offering.
3. Pharmaceutical Product Sales: Klea Pharmaceuticals subsidiary commercializing licensed medicines in Middle East and Africa. Initial portfolio of 57 medicines registered in UAE, targeting revenue of over AED 14.3 million (€3.9 million) by 2026, scaling to over AED 200 million (€50 million) by 2032.
4. Connected Health Solutions: Sale and deployment of VisioCheck telemedicine stations and related software solutions for telehealth use cases including teleconsultation, telemonitoring, and tele-expertise.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Klea Holding operates digitalized medical testing centers through its Smart Salem subsidiary in Dubai, providing rapid medical fitness assessments required for UAE residence and work visas. The company detects approximately 35 diseases in 7 minutes using AI and advanced diagnostics, delivering visa medical clearance in 30 minutes versus 10-15 days at traditional health centers. It also offers premium health & wellness testing, telemedicine solutions via Bewellthy/VisioCheck, and pharmaceutical distribution in the Middle East and Africa via Klea Pharmaceuticals.

Product overview

Klea Holding is an international group operating a diversified healthcare portfolio through its subsidiaries. The core business is Smart Salem, a network of three digitalized medical testing centers in Dubai offering rapid Medical Fitness assessments for visa purposes. The company has expanded into Saudi Arabia through Smart Health joint venture and entered pharmaceuticals via Klea Pharmaceuticals subsidiary. Additionally, Bewellthy (resulting from BewellConnect/WCS merger) provides telemedicine solutions including VisioCheck portable stations. The group operates on a 'scaling industries of the future' model, leveraging AI and digital technologies across its healthcare services.

Differentiator

Problem solved

Functional benefit

Brands

• Smart Salem: Digitalized medical fitness testing centers accredited by Dubai Health Authority (DHA) offering medical fitness assessments, health & wellness tests
• Smart Health
• Bewellthy
• Klea Pharmaceuticals

Products and services

• Smart Salem Digital Medical Testing Centers Network of digitalized medical testing centers in Dubai (DIFC, Dubai Knowledge Park, City Walk) accredited by Dubai Health Authority. Uses AI and advanced diagnostics to detect ~35 diseases in 7 minutes and deliver visa medical fitness clearance in 30 minutes.
• Medical Fitness Assessment Service Rapid medical fitness assessment service for UAE visa applicants, screening for HIV, hepatitis, tuberculosis and other diseases. Delivers results in 30 minutes vs 10-15 days traditional. Approximately 86% of 2025 group revenue.
• Health & Wellness Tests Premium preventive health check-up and wellness testing service for individuals and corporate clients. Higher-margin segment with 153% growth in 2025 at constant exchange rates.
• VisioCheck Telemedicine Station Portable telemedicine station (under 300g) for healthcare professionals, available in case, station, or modular health space configurations. Supports teleconsultation, home telemonitoring, hospital monitoring, tele-expertise, teleassistance, and tele-regulation.
• Bewellthy Connected Health Platform Teleconsultation and connected health solutions platform combining medical devices and software for telehealth use cases including enriched assisted teleconsultation, telemonitoring, and tele-expertise.
• Klea Pharmaceuticals Licensed Medicines Portfolio Marketing of licensed pharmaceutical products in Middle East and Africa markets. Initial portfolio of 57-59 medicines distributed via Al Khayyat Investments (AKI) covering 1,611 pharmacies (51% UAE) and 51 hospital groups. Target revenue AED 14.3 million by 2026, scaling to AED 200 million by 2032.

Quantifiable outcome

• 30-minute visa medical clearance vs 10-15 days traditional
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core, supporting and minor.

• Al Khayyat Investments (AKI)coreChannel Partner/ Reseller/ Distributor · 11 June 2026AKI is the pharmaceutical distribution partner for Klea Pharmaceuticals, providing nationwide coverage in UAE. Founded in 1965 with BinSina Pharmacy (first UAE pharmacy chain with 150+ pharmacies in UAE and Oman). AKI Healthcare division holds over 4% market share in Middle East pharmaceutical distribution (15%+ in UAE). Offers integrated logistics, regulatory excellence, and 100% cold chain control. Distribution network covers 1,611 pharmacies (51% UAE) and 51 hospital groups.
• Klea Pharmaceuticals Co-FounderscoreStrategic or Co-development Partner · 1 April 2026Two founders from international pharmaceutical industry holding stake alongside Klea Holding (46% initial, option to increase to 70% within three years). Founders bring significant expertise in development, registration and commercialization of pharmaceutical products in Middle East, Africa and Europe.
• CDMOs (Contract Development and Manufacturing Organisations)supportingTechnology or Integration · 1 April 202618 international production sites, all US FDA or EU GMP-certified, for outsourced pharmaceutical manufacturing. Industrial model for Klea Pharmaceuticals product supply.
• Mobadara InvestmentcoreStrategic or Co-development Partner · 31 March 2025New shareholder joining Smart Health to unlock potential in Saudi Arabia. Shareholder agreement where most future Capex & Opex will be covered by Mobadara Investment. Partnership enables Smart Health development in KAFD, Riyadh. Majority control transferred to Mobadara, with Klea Holding changing consolidation method from full consolidation to equity method.
• Smart Health Saudi Arabia PartnerscoreStrategic or Co-development Partner · 17 February 2023Two powerful partners for entering Saudi market. Joint venture Smart Health dedicated to deploying digital medical testing centers in Saudi Arabia. Incorporation completed September 2023.
• Whealthy Care Solutions (WCS)minorStrategic or Co-development Partner · 11 January 2023WCS merged with BewellConnect subsidiary to form Bewellthy, combining telemedicine and connected health solutions capabilities. Strategic consolidation of telehealth offerings.

Scale indicators10 records

Recent moves13 records

Expansion highlights6 records

Broad incumbents

• Aster DM Healthcare: UAE-headquartered healthcare conglomerate with hospitals, clinics and pharmacies across the Middle East and India. Comparable geographic footprint in the Gulf healthcare market with similar regulatory positioning in UAE and Saudi Arabia.
• Quest Diagnostics: Largest US clinical laboratory company providing diagnostic testing services. Relevant comparable as a scaled diagnostics platform, though focused on routine clinical lab testing rather than consumer-facing medical fitness assessments.
• Sonic Healthcare: Global diagnostics provider with extensive laboratory networks across Australia, Europe and the US. Comparable in operating model (high-volume diagnostic testing at scale) and in the breadth of routine and specialty testing menus.
• NMC Healthcare: Largest private healthcare provider in the UAE with hospitals, clinics and diagnostic services. Operates in the same UAE healthcare market with overlapping diagnostic and outpatient capabilities, though broader in scope (inpatient hospital focus).

Direct peers

• Synlab: Europe's largest medical diagnostics services provider operating centralized laboratory networks. Comparable to Klea in the diagnostics-services layer, though Synlab's model is centralized lab vs Klea's distributed digital center network.

Emerging players

• Doctolib: European digital health platform for appointment booking and teleconsultation. Comparable in digital health patient experience and consumer-facing healthcare delivery, with overlapping connected-health ambitions.
• Teladoc Health: Global leader in telemedicine and virtual care delivery. Comparable to Klea's Bewellthy/VisioCheck connected-health platform in the telemedicine delivery layer, though at vastly different scale and consumer vs enterprise orientation.
• Concentra Group: US occupational health and pre-employment medical testing network. Comparable in the dedicated employment/visa medical fitness testing niche that drives ~86% of Klea's revenue, though operating in a different regulatory and payment environment.

Regional players

• Gulf Healthcare International: UAE-based healthcare provider operating diagnostic centers and clinics across the Gulf. Comparable in operating physical diagnostic and clinical service locations in the same UAE market where Smart Salem competes.
• Al Borg Medical Laboratories: Leading Middle East medical laboratory chain headquartered in Saudi Arabia. Comparable as a regional diagnostics services provider with overlapping Gulf market footprint and similar test-menu breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/klea-holding

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Klea Holding